43 results
8-K
EX-10.1
XSNX
NovAccess Global Inc.
3 May 24
NovAccess Global Announces New License to Advance its Immunotherapy Platform
8:20am
as otherwise expressly provided herein, the Company will pay all fees and expenses incident to the performance of or compliance with this Section, including
8-K
EX-10.1
XSNX
NovAccess Global Inc.
28 Feb 24
Entry into a Material Definitive Agreement
3:06pm
provided herein, the Company will pay all fees and expenses incident to the performance of or compliance with this Section, including all fees
424B3
XSNX
NovAccess Global Inc.
19 Sep 22
Prospectus supplement
9:16am
; or
through any other method permitted under applicable law.
We will pay the expenses incident to the registration and offering of the shares
8-K
EX-10.1
86q9is29t237x mfb
10 May 22
Entry into a Material Definitive Agreement
8:22am
424B3
2ger2g5v
7 Apr 11
Prospectus supplement
12:00am
424B3
uj3xef
6 Jul 10
Prospectus supplement
12:00am
8-K
EX-10.1
ihflgzzfl
1 Apr 10
Entry into a Material Definitive Agreement
12:00am
424B3
jyp 731n6doarh
17 Apr 08
Prospectus supplement
12:00am
8-K
EX-10.1
hm6ey 9wndm
2 Apr 08
Entry into a Material Definitive Agreement
12:00am
10-K/A
p9x4n4g2p1971lpufnwt
1 Apr 08
Annual report (amended)
12:00am
S-1/A
q4ea nvqsckgbwclkqht
5 Mar 08
IPO registration (amended)
12:00am